L-α-Acetylmethadol-Induced Tissue Alterations in Mice

References

• Axelrod J. Possible mechanism of tolerance to narcotic drugs. Science (1956); 124: 236
   Google Scholar
• Kato R., Gillete J. R. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J. Pharmacol. Exp. Ther. (1965); 150: 285
   PubMed Web of Science ®Google Scholar
• Sladek N. E., Chaplin M. D., Mannering G. L. Sex-dependent differences in drug metabolism in the rat. IV. Effect of morphine administration. Drug Metab. Disp. (1973); 4: 244
   Google Scholar
• Amzel V., van der Hoeven T. Morphine-induced depression of the hepatic microsomal drug-metabolizing enzyme-Effect on the lipid component. Biochem. Pharmacol. (1980); 29: 658
   PubMed Web of Science ®Google Scholar
• Guarantz D., Correia M. A. Morphine-mediated effects on rat hepatic heem and cytochrome P-450 in vivo, antagonism by naltrexone in the liver. Biochem. Pharmacol. (1981); 30: 1529
   PubMed Web of Science ®Google Scholar
• Buening M. K., Franklin M. R. SKF525-A inhibition, induction and 452-nm complex formation. Drug Metab. Disp. (1975); 4: 244
   Web of Science ®Google Scholar
• Franklin M. R. Inhibition of mixed function oxidations by substrate forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmac. Ther. A. (1977); 2: 227
   Web of Science ®Google Scholar
• Roberts S. M., Frankl M. R. Modification of hepatic microsomal oxidative metabolism in rats by the opiate maintenance drugs acetylmethadol, propoxyphene and methadone. Life Sci. (1979); 25: 845, it is
   PubMed Web of Science ®Google Scholar
• Gumbrecht J. R., Franklin M. R. The formation of cytochrome P-450-metabolic intermediate complexes from amines, in the isolated perfused liver. Xenobiotica (1979); 9: 547
   PubMed Web of Science ®Google Scholar
• Masten L. W., Peterson G. R., Burkhalter A., Way E. L. Tolerance to methadone lethality and microsomal enzyme induction in mice tolerant to and dependent on morphine. Drug Alcohol Dep. (1980); 5: 27
   PubMed Web of Science ®Google Scholar
• Datta R. K., Johnson E. A., Stenger R. J. Effects of morphine sulfate on NAPH-cytochrome C reductase and cytochrome P-450 of mouse liver microsomes. Arch. Int. Pharmacodyn. (1976); 223: 180
   PubMedGoogle Scholar
• Masten L. W., Price S. R., Burnett C. J. Microsomal enzyme induction following repeated oral administration of LAAM. Res. Commun. Chem. Pathol. Pharmacol. (1978); 20: 1
   PubMedGoogle Scholar
• Peterson G. R., Hostitler R. M., Lehman T., Covault H. P. Acute inhibition of oxidative drug metabolism by propoxyphene (Darvon). Biochem. Pharmacol. (1979); 28: 1783
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Smith C. Biochemical aspects of toxic metabolites—Formation, detoxication and covalent binding. “Biological Reactive Intermediates”, D. J. Jollow, J. J. Kocsis, R. Snyder, H. Vainio. Plenum, New York (1972); 42
   Google Scholar
• Hicks R., Hulbert P. B., Kurzeia E. N. Inhibition of induction of drug-metabolism in relation to dextro-propoxyphene-induced glutathione depletion in isolated hepatocytes. Proc. Br. Pharmaceut. Soc (1981); 3: 302
   Google Scholar
• James R. C., Harbison R. D. Hepatic glutathione and hepatotoxicity. Effects on cytochrome P-450 complexing compounds SKF525-A, L-α-acetylmethadol (LAAM), norLAAM, and piperonyl butoxide. Biochem. Pharmacol. (1982); 31: 1829
   PubMed Web of Science ®Google Scholar
• James R. C., Goodman D. R., Harbison R. D. Hepatic glutathione and hepatotoxicity: Changes induced by selected narcotics. J. Pharmacol. Exp. Ther. (1982a); 221: 708
   PubMed Web of Science ®Google Scholar
• Meister A., Tate S. S. Glutathione and related γ-glutamyl compounds: Biosynthesis and utilization. Ann. Rev. Biochem. (1976); 45: 559
   PubMed Web of Science ®Google Scholar
• Cherubin C. E., Kane S., Weinburger D. R., Wolfe E., McGinn T. Persistence of transaminase abnormalities in former addicts. Ann. Int. Med. (1972); 76: 385
   PubMed Web of Science ®Google Scholar
• Kreek M. J., Dodes L., Kane S., Knobler J., Martin R. Long term methadone maintenance therapy: Effects on liver function. Ann. Int. Med. (1972); 77: 598
   PubMed Web of Science ®Google Scholar
• Klein N. C., Magida M. G. Propoxyphene hepatotoxicity. Dig. Dis. (1971); 16: 467
   Web of Science ®Google Scholar
• Lee T. H., Rees P. J. Hepatotoxicity of dextro-propoxyphene. Br. Med. J. (1977); 2: 296
   PubMed Web of Science ®Google Scholar
• Ostor A. G. The medical complications of narcotic addiction. Med. J. Aust. (1977); 1: 497
   PubMed Web of Science ®Google Scholar
• Norris R. F., Potter H. P. Hepatic inflammation in narcotic addicts. Viral hepatitis a possible cause. Arch. Env. Health (1965); 11: 662
   PubMed Web of Science ®Google Scholar
• Gorodetzky C. W., Sapira J., Jasinski D. R., Martin W. R. Liver disease in narcotic addicts. I. The role of the drug. Clin. Pharmacol. Ther. (1968); 9: 720
   PubMed Web of Science ®Google Scholar
• Hurwitz A. Narcotic effects on anionic dye disposition in mice. Gastroenterol. (1979); 76: 1285
   Web of Science ®Google Scholar
• Thureson-Klein A., Wang-Yang J., Ho I. K. Lipid accumulation in mouse hepatocytes after morphine exposure. Experentia (1978); 34: 773
   PubMedGoogle Scholar
• Chang Y. H., Ho I. K. Effects of acute and continuous morphine administration on serum glutamate oxalacetate transaminase and glutamate pyruvate transaminase activities in the mouse. Biochem. Pharmacol. (1979); 28: 1373
   PubMed Web of Science ®Google Scholar
• Needham W. P., Shuster L., Kanel G. C., Thompson M. L. Liver damage from narcotics in mice. Toxicol. Appl. Pharmacol. (1981); 58: 157
   PubMed Web of Science ®Google Scholar
• Ellman G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959); 82: 70
   PubMed Web of Science ®Google Scholar
• Reitman S., Frankel S. A colorimetric method for the determination of serum glutamic-oxalacetic and glutamic-pyruvic transaminases. Am. J. Clin. Pathol. (1957); 28: 56
   PubMed Web of Science ®Google Scholar
• Tiffany T. O., Jansen J. M., Burtis C. A., Overton J. B., Scott C D. Enzymatic kinetic rate and end-point analyses of substrate, by use of GeMSAEC fast analyzer. Clin. Chem. (1972); 18: 829
   PubMed Web of Science ®Google Scholar
• Fabiny D. L., Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the Centrifichem. Clin. Chem. (1971); 17: 697
   Google Scholar
• Emmerson J. L., Gison W. R., Harris P. N., Todd G. C., Pierce E. C., Anderson R. C. Short-term toxicity of propoxyphene salts in rats and dogs. Toxicol. Appl. Pharmacol. (1971); 19: 452
   PubMed Web of Science ®Google Scholar
• Hogberg J., Kristoferson A. A correlation between glutathione levels and cellular damage in isolated hepatocytes. Eur. J. Biochem. (1977); 74: 77
   PubMedGoogle Scholar
• Mukhtar H., Bend J. R. Serum glutathione-S-transferase: Perinatal development, sex differences, and effect of carbon tetrachloride administration on enzyme activity in the rat. Life Sci. (1977); 21: 1277
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. (1973); 187: 211
   PubMed Web of Science ®Google Scholar
• Evans M. A., Harbison R. D. Cocaine-induced hepatic necrosis in mice. Toxicol. Appl. Pharmacol. (1978); 45: 739
   PubMed Web of Science ®Google Scholar
• Docks E. L., Krishna G. Role of glutathione in chloroform-induced hepatotoxicity. Exp. Mol. Pathol. (1976); 24: 13
   PubMed Web of Science ®Google Scholar
• Reitz K. C., Steele W. J. Mechanism of inhibition of protein synthesis by morphine in rat brain and liver. Mol. Pharmacol. (1982); 22: 706
   PubMed Web of Science ®Google Scholar